Under the 808 nm light irradiation, NP2 combined with PD‐L1 treatment is found to enhance chemotherapy and photodynamic immunotherapy in prostate tumors simultaneously, providing a new paradigm for clinical multimodal treatment of tumors. Here, CD274 is linked to prostate neoplasm.